Product Details
Central Action of PT-141 (10mg) Peptide Injection
PT-141 (10mg) Peptide Injection (Bremelanotide) is a cyclic heptapeptide functional agonist that acts centrally within the hypothalamus rather than locally on vascular tissue. Chemically structured as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, it selectively binds central melanocortin receptors (MC3R and MC4R) to elicit autonomic dopamine signaling. Consequently, primary investigators sourcing reference standards via aminos research channels or evaluating top suppliers across research chem hq rely on Biopharma for verified analytical consistency in 2026.
Why Choose PT-141 (10mg) Peptide Injection?
Unmatched Central Nervous System Specificity
When evaluating reproductive endocrine signaling or comparing trial models to alternative metabolic agents like retatrutide for sale usa, obtaining a pure melanocortin agonist delivers three distinct analytical advantages:
- Central Mechanism: Bypasses peripheral nitric oxide pathways to trigger autonomic libido responses directly in brain centers.
- Gender-Neutral Signaling: Recognized as one of the best peptides for women and male animal models in libido modulation studies.
- Cost-Effective Mass: The 10mg mass lowers overall peptide injection cost and general peptides cost across long-term testing protocols.
Furthermore, procurement teams evaluating verified peptides for sale can browse our catalog or buy hcg peptide options for broader endocrine research.
Key Benefits
Targeted Hypothalamic Activation Pathways
Investigating PT-141 (10mg) reveals profound effects on central motivation networks. Analysts record these key physiological milestones during testing:
- Dopaminergic Neurotransmission: Crosses blood-brain pathways to stimulate dopamine release in the medial preoptic area (mPOA).
- Non-Vascular Activation: Operates entirely independent of cardiovascular PDE-5 pathways to isolate neural response metrics.
- Extended Response Window: Displays prolonged receptor occupancy and persistent biological signal transmission in 2026 models.
Reconstitution Instructions
Preparation Guidelines for PT-141 (10mg) Peptide Injection
To reconstitute PT-141 (10mg) Peptide Injection safely without damaging sequence stability, laboratory personnel must follow these steps:
- First, wipe the top rubber stopper of the vial using a sterile 70% isopropyl alcohol swab.
- Next, add 1.0 mL to 2.0 mL of Bacteriostatic Water slowly down the glass wall of the container.
- Then, allow the lyophilized cake to dissolve naturally without shaking or agitation.
- Gently swirl the vial until the solution becomes completely clear and transparent.
- Finally, place the reconstituted liquid inside a laboratory refrigerator between 2°C and 8°C.
For exact concentration calculations during lab protocols, access our online Dosage Calculator tool.
Typical Dosing Guidelines
Parameters for 2026 In Vitro and In Vivo Protocols
Standard Dosage Range: Researchers evaluate test doses from 1.0mg to 1.75mg per administration during PT-141 (10mg) Peptide Injection evaluation cycles.
Administration Method: Conduct trial testing via precise subcutaneous injection in controlled laboratory settings.
Protocol Timing: Administer test doses 2 to 4 hours prior to assessing behavioral response parameters in 2026 study designs.
Storage Guidelines: Store lyophilized powder sealed in a freezer (-20°C). Refrigerate reconstituted liquid between 2°C and 8°C for up to 30 days.
Every analytical lot from Biopharma undergoes independent HPLC purity testing and MS identity validation. Consequently, we guarantee over 99% purity across all 2026 shipments.
Disclaimer: All products available on this site are strictly intended for laboratory, in vitro, and scientific research applications only. They are not intended for human consumption, clinical diagnostic procedures, or therapeutic administration.











Reviews
There are no reviews yet.